Private Equity Private Equity
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
20100527-NOXXON Pharma AG Raises -200 33 Million in Series D
NOXXON Pharma AG raises €33 million in Series D Round Berlin, Germany, May 27, 2010 – NOXXON Pharma AG (NOXXON), a company focused on the development of mirror image oligonucleotide therapeutics called Spiegelmers ®, announced today the successful closing of a €33 million Series D round of financing. The round was led by new investor, NGN Capital, and joined by existing investors TVM Capital, Sofinnova Partners, Edmond de Rothschild Investment Partners, Seventure Partners, VC Fonds Technologie Berlin GmbH, Dow Venture Capital, FCP OP MEDICAL BioHealth- Trends, IBG Beteiligungsgesellschaft Sachsen-Anhalt mbH, the Dieckell Group, and others. The funds raised will be used primarily for the ongoing clinical and pre-clinical development of NOXXON´s lead products NOX-E36, NOX-A12, and NOX-H94 in the fields of diabetic complications, oncology and hematology. These products are high-potency inhibitors of their respective targets, generated with NOXXON’s proprietary Spiegelmer ® technology. Spiegelmers ® are marked by their biostability and an extremely low potential for toxic or immunogenic side effects. “This investment provides NOXXON with the funds to advance the clinical development of our three most advanced in-house programs without the need for additional external support. NGN´s decision to lead this round is a testament to the value of the Spiegelmer ® technology and the commercial potential of the development programs pursued by NOXXON.” stated NOXXON’s CEO Dr. Frank Morich. Peter Johann, a Managing General Partner at NGN Capital, commented: “We are very excited about NOXXON’s platform and the product opportunities which can be created from it. The Company and its experienced management team made significant progress over the last years bringing two Spiegelmers ® into the clinic and one more close to clinical development. -
Shareholder Meeting
17 June 2009 HarbourVest Global Private Equity Limited Informal Meeting for Shareholders Welcome Sir Michael Bunbury Chairman, HVPE HarbourVest and HVPE Attendees Sir Michael Bunbury Chairman of HVPE D. Brooks Zug Senior Managing Director and Founder of HarbourVest; Director of HVPE George Anson Managing Director of HarbourVest; Director of HVPE Steve Belgrad CFO of HVPE Amanda McCrystal Head of Investor Relations and Communications for HVPE 2 Agenda I. Welcome Sir Michael Bunbury II. Overview of the Manager – HarbourVest D. Brooks Zug III. HVPE Review Steve Belgrad • Financial Highlights • Portfolio • Commitments and Balance Sheet • Trading and Investor Relations • HVPE Outlook IV. Outlook for Private Equity George Anson V. Summary / Questions and Answers Steve Belgrad 6/1/2009 3 Overview of the Manager – HarbourVest D. Brooks Zug Senior Managing Director and Founder, HarbourVest Director, HVPE Overview of the Investment Manager – HarbourVest Partners Largest Private Independent, 100% owner-managed private equity fund-of-funds Equity Founders began private equity investing in 1978 Fund-of-Funds Manager with Total capital raised over 25 years of $30 billion Experienced, Global 78 investment professionals in Boston, London and Hong Kong Team together with a support staff of more than 140 Focus on three private equity investment strategies: primary Consistent partnerships, secondary investments, direct investments Private Equity Strategy Four principal product lines: U.S. fund-of-funds, non-U.S. fund-of-funds, secondary-focused funds, direct / co-investment funds Demonstrated One of the longest track records in the industry Upper Quartile Achieved by the same professionals that manage the portfolio today Investment Demonstrated top quartile performance across all private equity Performance strategies1 __________________ Note: (1) Where relevant benchmarks exist. -
What to Consider Before Contacting a Venture Capital Investor
Deliverable 6: Network of private investors Background material for AAL project participants March 2014 (updated NHG 15.1.2016) Copyright statement AAL2Business - Report titled “Network of private investors - Background material for AAL project participants“ Report for Ambient Assisted Living Association, Brussels Date April 2014 Author(s) Nordic Healthcare Group Responsible Administrator: AAL Association Brussels Project name: AAL2Business Publisher: Ambient Assisted Living Association Rue de Luxembourg, 3, 2nd floor B-1000 Brussels, Belgium Phone +32 (0)2 219 92 25 email: [email protected] About Ambient Assisted Living Association: The Ambient Assisted Living Association (AALA) is organizing the Ambient Assisted Living Joint Programme (AAL JP). The AAL JP aims at enhancing the quality of life of older people and strengthening the industrial base in Europe through the use of Information and Communication Technologies (ICT). Therefore, the AAL JP is an activity that operates in the field of services and actions to enable the active ageing among the population. The programme is financed by the European Commission and the 22 countries that constitute the Partner States of this Joint Programme. See more at: http://www.aal-europe.eu/ The information and views set out in this report are those of the author(s) and do not necessarily reflect the official opinion of the AALA. The AALA does not guarantee the accuracy of the data included in this study. Neither the AALA nor any person acting on the AALA’s behalf may beheld responsible for the use which may be made of the information contained therein. All rights reserved by AALA. © 2014 Ambient Assisted Living Association, Brussels 2 Contents 1 Introduction and content overview 2 Funding opportunities and availability in Europe 3 Considerations before seeking funding 4 Choosing the right type of funding 5 Investor contacts and event listings • Accelerator Programs & Business angels • Venture capital • Events • Other useful sources 3 Introduction to material . -
John Markland Is a Partner in Dechert’S London Office
John D. Markland Partner London | 160 Queen Victoria Street, London, UK EC4V 4QQ T +44 20 7184 7887 | F +44 20 7184 7001 [email protected] Services Banking and Financial Institutions > Corporate Finance and Capital Markets > Global Finance > Leveraged Finance > Private Equity > John Markland is a partner in Dechert’s London office. He is co-head of the firm’s global leveraged finance practice and is consistently recognized as one of Europe’s most “highly experienced finance practitioner[s]” Chambers UK (2017). According to The Legal 500 (2018) he is "a true and rare rock star of leveraged finance". In the 2021 edition of Chambers UK, Mr. Markland is described by clients as being “an excellent partner who is very knowledgeable. He is a formidable negotiator and provides invaluable advice around complex mechanics in contractual agreements," as well as being “extremely commercial and pragmatic." He is also ranked and listed as a ‘leading individual’ for acquisition finance in The Legal 500 UK, 2021. Mr. Markland recently won a special commendation in The Legal Business Corporate Team of the Year Awards 2019 for his role in advising South Korea's SK hynix Inc., the single largest investor in the Bain Capital consortium's US$18 billion takeover of Toshiba's memory chip business unit last year, which is still the largest private equity-backed acquisition globally since 2015 (Thomson Reuters). Prior to joining Dechert in November 2016, Mr. Markland was a partner at Kirkland & Ellis for over 12 years. At Kirkland, Mr. Markland founded and led the European debt finance practice, which won the Dow Jones Private Equity News “Finance Team of the Year” Award for Excellence in Advisory Services in Europe and was consistently top-ranked in Chambers. -
Private Equity Analyst
PRIVATE EQUITY ANALYST NOVEMBER 2020 Women to Private Equity’s Top Female Talent of Today and Tomorrow p. 7 10 VCs Grooming Game-Changing Startups p. 13 Watch LP Cycles Ad HFA+PEA-Ltr DR080420.pdf 1 8/4/20 5:43 PM Private equity investing has its cycles. Work with a secondary manager who’s C experienced them all. M Y CM MY As leaders of the secondary market, the Lexington Partners team CY draws on more than 400 years of private equity experience. CMY Through all types of business cycles, we have completed over K 500 secondary transactions, acquiring more than 3,000 interests managed by over 750 sponsors with a total value in excess of $53 billion. Our team has excelled at providing customized alternative investment solutions to banks, financial institutions, pension funds, sovereign wealth funds, endowments, family offices, and other fiduciaries seeking to reposition their private investment portfolios. If you have an interest in the secondary market, our experience is second to none. To make an inquiry, please send an email to [email protected] or call us at one of our offices. Innovative Directions in Alternative Investing New York • Boston • Menlo Park • London • Hong Kong • Santiago • Luxembourg www.lexingtonpartners.com Includes information regarding six funds managed by Lexington’s predecessor formed during the period 1990 to 1995. This information is provided for informational purposes only and is not an offer to sell or solicitation of offers to purchase any security. Private Equity Analyst November 2020 contents Volume XXX, Issue 11 Fund News u The Roundup Comment Clayton Dubilier Collects About $14B for Latest Buyout Fund 26 H.I.G. -
View, a Private Real Estate Investment Manager Focused Primarily on Private Real Estate Debt Strategies
FOCUS Ranan Z. Well Corporate & Securities Mergers & Acquisitions Chair, Investment Management M&A Private Equity Co-Chair, Private Equity Investment Management Mergers & Acquisitions Washington, DC Insurance Transactional & Regulatory 202.419.8404 Solutions Financial Services [email protected] Investment Management Private Investment Funds Institutional Investors Health Law Ranan Well represents public and private companies, private equity firms and Special Situations other financial services firms and investors in a broad range of corporate and BAR ADMISSIONS transactional matters, including mergers and acquisitions, joint ventures and strategic transactions, equity investments and restructurings. District of Columbia Maryland As chair of Stradley Ronon’s Investment Management Mergers & Acquisitions Practice, Ranan works within the firm’s premier Investment Management EDUCATION Group in representing asset management, wealth management, private equity J.D., Boston University School of Law and other financial services firms and investors in purchases and sales of B.A., Yeshiva University registered investment advisers, mutual fund adoptions and mergers of registered investment companies, joint ventures and strategic transactions, and equity investments. In addition, Ranan advises institutional investors in their investments into hedge funds and private equity funds, including the negotiation and execution of side letter agreements, and has successfully negotiated more than 45 investments, totaling in excess of $3.9 billion. He further counsels sponsors in connection with the structuring and formation of private investment funds. Ranan earned a certificate in FinTech from Harvard’s Office of the Vice Provost for Advances in Learning (VPAL), and previously served as a member of the Law360 Mergers & Acquisitions Editorial Advisory Board. RESULTS Ranan’s experience includes the representation of:* Investment Management . -
Proxy Statement to a Term of Three Years Each, Or Until Their Successors Have Been Elected and Qualified; and 2
MESSAGE FROM OUR CHAIRMAN AND OUR CEO Dear Stockholders: We are pleased to invite you to join us for the 2020 significant experience in the life sciences industry, Annual Meeting of Stockholders of NextCure, Inc., to serve as Class I directors for three-year terms our first as a public company, to be held on ending in 2023. Beginning on page 6, you will find Thursday, June 11, at 10 a.m. Eastern Time, detailed information about the qualifications of virtually over the internet at both our director nominees and our continuing www.virtualshareholdermeeting.com/NXTC2020, directors, who we believe are a strong group to during which time you will be able to vote your represent your interests. Our Board of Directors is shares electronically and submit questions. committed to governance practices that are appropriately tailored to our business and to 2019 was a transformative one for our company. guiding NextCure to deliver on our commitment to We reported positive initial clinical data from the discovering and developing novel, first-in-class Phase 1 portion of our Phase 1/2 clinical trial of our immunomedicines to treat cancer and other lead product candidate, NC318, and initiated the immune-related diseases by restoring normal Phase 2 portion of that trial. We successfully immune function. completed our initial public offering and a follow-on offering, raising an aggregate of We extend our gratitude to Tim Shannon, who left $258.5 million. In addition, in connection with our the Board of Directors in March after more than initial public offering, we adopted a four years of service, for his invaluable comprehensive suite of public company contributions to our early growth and direction. -
PRIT Fund Managers Domestic Equity INTECH Investment Management
PRIT Fund Managers Private Equity 1818 Fund II, LP (The) Domestic Equity Advent International INTECH Investment Management, LLC Alchemy Partners Pacific Investment Management Company (PIMCO) Alta Communications State Street Global Advisors American Securities International Equities APA German European Ventures Baillie Gifford APAX Partners & Co. Marathon Asset Management, Ltd Apollo Investments Management Mondrian Investment Partners Asia Pacific Trust State Street Global Advisors Austin Ventures Core Fixed Income Bain Capital Access Capital Strategies, LLC Battery Ventures Partners AFL-CIO Housing Investment Trust Belmont Capital Partners BlackRock, Inc. Berkshire Partners, LLC Community Capital Management Blackstone Group Loomis Sayles & Company, LP Boston Ventures Pacific Investment Management Company (PIMCO) Bridgepoint Capital Limited Value-Added Fixed Income Brown Brothers Ashmore Investment Management Ltd Candover Eaton Vance Institutional Funds Capital Resource Partners Fidelity Mnagement Trust Company Carlyle Partners ING Investment Management Castile Ventures Loomis, Sayles & Company, L.P. Centerbridge Capital Partners Pacific Investment Management Company (PIMCO) Charles River Ventures Shenkman Capital Management Charlesbank Capital Partners Distressed Debt Managers Charterhouse Capital Partners Angelo, Gordon & Co. Chesquers Capital Avenue Capital Group Code Hennessey & Simmons Crescent Capital Group Commonwealth Capital Ventures GSO Capital Partners Crossroads Capital Oaktree Capital Management Crossroads Group Trust Company of the West CVC European Equity Partners Wayzata Investment Partners Cypress Group LLC Emerging Markets Equity Managers Cypress Merchant Banking Ashmore EMM, L.L.C. DLJ Merchant Banking GMO LLC El Dorado Ventures State Street Global Advisors Equitable Capital Management T. Rowe Price Essex Woodlands Natural Resources Ethos Private Equity Denham Capital Management Exponent Partners Jennison Associates First Reserve Corporation Quantum Energy Partners Flagship Ventures T. Rowe Price Forstmann, Little & Co. -
The PEI Awards 2015: Mid-Market Firm of the Year in Asia
13297 Private Market Fundraising Advert_Layout 1 11/10/2013 16:42 Page 1 Available as an eBook PRIVATE MARKET FUNDRAISING World-class fundraising techniques for private equity, debt, real estate and infrastructure funds And the • Acquire insight into how LPs are viewing the fundraising environment and how they are approaching portfolio construction winner is ... • Optimise your firm’s preparation with detailed timelines and plans As a reader of Private Equity International, you’ll be familiar • Take full advantage of ‘non-marketing’ situations for marketing with this next very special section, which details the firms, funds and deals that stood out from the crowd in 2015. • Familiarise yourself on how to work with placement agents for an optimal campaign and with gatekeepers to get your foot in the door Each year, our global edit team works through the views and opinions of colleagues and contacts in the market to build a list of nominees for what is the private equity • Nail that all important face-to-face presentation industry’s most comprehensive set of awards. The chal- lenge is to select the few who have caught the eye of …plus much more many. In addition to drawing up a shortlist of four nomi- nees per category, we include a fifth ‘write-in’ option for each category to let readers input their own preferences. Attracting thousands of votes from all over the world, the results provide evidence of the dynamic and diverse nature of private equity. AVAILABLE NOW While it’s the industry itself that ultimately chose this year’s Order your copy of this essential title today: slate of winners, there is one award given solely at our editorial team’s discretion: the PEI Game Changer Award. -
CEO Monthly Fintech Market Analysis
CEO Monthly FinTech Market Analysis October 2016 The Only Investment Bank Focused Exclusively on Financial Technology FT Partners Awarded “Boutique Investment Bank of the Year” “Deal of the Decade” Financial Technology Partners Steve McLaughlin 555 Mission St., 23rd Floor Managing Partner San Francisco, CA 94105 www.ftpartners.com Tel: 415.992.8880 Tel: 415.512.8700 [email protected] Highly Confidential and proprietary information. Unauthorized distribution without prior consent from Financial Technology Partners LP or FTP Securities LLC (together “FT Partners”) is strictly prohibited. This communication should not be regarded as an offer to sell or as a solicitation of an offer to buy any financial product or service, nor is it an official confirmation of any transaction, or representative of an official position or statement of Financial Technology Partners LP, FTP Securities LLC or any other related entity. FTP Securities LLC is a FINRA registered broker-dealer. © 2016 Insurance Technology and Services Market Analysis FT Partners’ Research – InsurTech Industry Report Prepare for the InsurTech Wave: Overview FT Partners' 248-page report provides an in-depth look at the major waves of innovation and disruption that are beginning to of Key Insurance Technology Trends radically alter the insurance industry. Additional highlights of the report include: • An analysis of specific trends across: Insurance Distribution, Sales, Marketing and Engagement, Data and Analytics and Insurance Administration • The responses of incumbents -
Powerpoint Template
BeBeez Magazine 5 maggio 2021 - n.22/2021 - Le news del private capital dal 29 maggio al 4 giugno 2021 Per le news del weekend appuntamento lunedì su BeBeez A fine marzo c’erano 61,5 mld euro di crediti deteriorati sui libri dei primi 6 gruppi bancari italiani. Erano 65 mld a fine 2020 In DATI E ANALISI a pag. 22 EdiBeez srl - Corso Italia, 22 – 20122 Milano – P IVA 09375120962 1 I SOMMARIO GREENBEEZ 3 PRIVATE EQUITY & SPAC in Italia 3 VENTURE CAPITAL 7 PRIVATE EQUITY e VENTURE CAPITAL all’estero 8 PRIVATE DEBT 13 REAL ESTATE in Italia 15 REAL ESTATE all’estero 16 CRISI E RILANCI 19 CROWDFUNDING 20 FINTECH 20 ANGELS & INCUBATORS 21 NPL 21 COMMENTI E OPINIONI 22 DATI E ANALISI 22 LIBRI 23 ARTE & FINANZA 24 EdiBeez srl - Corso Italia, 22 – 20122 Milano – P IVA 09375120962 2 GREENBEEZ Joint venture tra Amaranto Holding e Byom. Acquisirà impianti fotovoltaici in difficoltà 2 giugno 2021 - Amaranto Holding e Byom hanno lanciato Fusion, una joint venture paritetica finalizzata all’acquisto di impianti fotovoltaici in difficoltà finanziaria e avviare iniziative nel campo della generazione distribuita, con particolare riferimento alle comunità energetiche. I primi tre impianti da acquisire sono stati già individuati. Leggi tutto. PRIVATE EQUITY & SPAC LA SETTIMANA DEL PRIVATE EQUITY IN ITALIA Gyrus Capital si compra l’attività di consulenza alla PA ed enti sanitari di PwC Italia 4 giugno 2021 - Lo svizzero Gyrus Capital ha siglato un accordo di carve-out con PwC Italia per rilevare l‘attività di consulenza alla pubblica amministrazione ed enti sanitari in tema di Transformation, Technology, Digitalization e Project Management. -
Private Equity & Venture Capital in a Changing Global Environment
CUBIERTA-INFORME-2017-aaff.pdf 2 25/4/17 13:07 Príncipe de Vergara, 55 4º D • 28006 Madrid tel. (34) 91 411 96 17 • www.ascri.org C M Y CM MY CY CMY K 2017 SURVEY Venture Capital & Private Equity in Spain SURVEY Venture Capital & Private Equity in Spain 2017 WITH THE SPONSORSHIP OF Private Equity & Venture Capital in a changing global environment SURVAY 2017 Sponsor by: Private Equity & Venture Capital in Spain THIS SURVEY WAS ELABORATED BY: Dominique Barthel (ASCRI Managing Director) and Ángela Alférez (ASCRI Head of Research), from the data obtained and collected by José Martí Pellón (Universidad Complutense of Madrid) and Marcos Salas de la Hera (Webcapitalriesgo.com) Copyright ASCRI ® 2017 The Spanish Venture Capital & Private Equity Association (ASCRI) is the industry body that units and represents the sector to the authorities, Government, institutions, investors, entrepreneurs and media. ASCRI regularly communicates and provides statistics and updated information regarding the developments of the tax and legal framework. ASCRI also organizes a range of activities (training courses, events and round tables) for the members and general public in order to disseminate and reinforce the contribution of the Venture Capital & Private Equity industry for the economy and growth of SMEs in Spain. ASCRI comprises almost 100 national and international Venture Capital & Private Equity firms, five limited partners and over 50 service providers, spreading and ensuring the professional standards among its members: transparency, good governance